Concepedia

Author

Andrew Charlesworth

Nottingham Biomedical Research CentreORCID

Also Known As

A Charlesworth, A. Charlesworth, Andrew Charlesworth, Andrew J. Charlesworth, Arthur Charlesworth, Charlesworth, A, Charlesworth, Andrew, Charlesworth, Andrew J

234

Publications

7.4K

Citations

34

H-Index

147

Concepts

All Affiliations

Nottingham Biomedical Research CentreSahlgrenska University HospitalUniversity of HullUniversity of BresciaUniversity of Nottingham
AC

About

Andrew Charlesworth is an author at Nottingham Biomedical Research Centre specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

5

5

136

2

Arts

4

4

168

3

Business

4

4

109

4

Health Sciences

3

3

203

5

Education

2

2

39

Andrew Charlesworth

×

60

Publications

6.7K

Citations

32

H-Index

YearCitations

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation

David A. Morrow, Elliott M. Antman, Andrew Charlesworth,

Circulation

2000

1.6K

Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure

Hans L. Hillege, Armand R. J. Girbes, Pieter Jan de Kam,

Circulation

2000

1K

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET

Karl Swedberg, Lars Olsson, Andrew Charlesworth,

European Heart Journal

2005

642

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

David A. Morrow, Elliott M. Antman, Robert P. Giugliano,

The Lancet

2001

293

Oral Glycoprotein IIb/IIIa Inhibition With Orbofiban in Patients With Unstable Coronary Syndromes (OPUS-TIMI 16) Trial

Christopher P. Cannon, Carolyn H. McCabe, Robert G. Wilcox,

Circulation

2000

288

The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET

Michel Komajda, Stefan D. Anker, Andrew Charlesworth,

European Heart Journal

2006

227

Symptoms in Patients With Heart Failure are Prognostic Predictors: Insights From COMET

Inger Ekman, John G.F. Cleland, Karl Swedberg,

Journal of Cardiac Failure

2005

201

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Marco Metra, Christian Torp‐Pedersen, Karl Swedberg,

European Heart Journal

2005

179

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Christian Torp‐Pedersen, Marco Metra, Andrew Charlesworth,

Heart

2007

173

Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study

Gad Cotter, Christopher P. Cannon, Carolyn H. McCabe,

American Heart Journal

2003

150

Page 1